Oligogenic inheritance in long QT syndrome and hypertrophic cardiomyopathy

被引：0

作者：

Dean, John ^{[1
]}

Brown, C. ^{[1
]}

Walker, D. ^{[1
]}

Clark, C. ^{[1
]}

Kelly, K. ^{[1
]}

Broadhurst, P. ^{[2
]}

Choy, A-M ^{[3
]}

Lam, W. ^{[4
]}

Murday, V. ^{[5
]}

Goudie, D. ^{[6
]}

Grieve, J. ^{[7
]}

机构：

[1] Univ Aberdeen, Dept Med Genet, Aberdeen AB9 1FX, Scotland

[2] Aberdeen Royal Infirm, Dept Cardiol, Aberdeen, Scotland

[3] Univ Dundee, Dept Cardiol, Dundee DD1 4HN, Scotland

[4] SE Scotland Reg Genet Serv, Edinburgh, Midlothian, Scotland

[5] Yorkhill Childrens Hosp, Dept Med Genet, Glasgow, Lanark, Scotland

[6] Ninewells Hosp, Dept Human Genet, Dundee DD1 9SY, Scotland

[7] Univ Aberdeen, Dept Forens Med, Aberdeen AB9 1FX, Scotland

来源：

JOURNAL OF MEDICAL GENETICS | 2009年 / 46卷

关键词：

D O I：

暂无

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

引用

页码：S26 / S26

页数：1

共 50 条

[1] Implantable Defibrillators in Long QT Syndrome, Brugada Syndrome, Hypertrophic Cardiomyopathy, and Arrhythmogenic Right Ventricular Cardiomyopathy
Dohadwala, Mustafa
Link, Mark S.
[J]. CARDIOLOGY CLINICS, 2014, 32 (02) : 305 - +
[2] Hypertrophic cardiomyopathy, long QT interval and coronary perforator disease in the Noonan syndrome
de Gregorio, Cesare
Recupero, Antonino
[J]. JOURNAL OF CARDIOVASCULAR MEDICINE, 2020, 21 (02) : 161 - 163
[3] Long QT syndrome in extensive infective endocarditis complicating hypertrophic obstructive cardiomyopathy
Yuan, Shi-Min
Demosthenous, Eugene
Coman, Vera
[J]. KARDIOLOGIA POLSKA, 2009, 67 (01) : 53 - 57
[4] Genetic testing and cascade screening in pediatric long QT syndrome and hypertrophic cardiomyopathy
Knight, Linda M.
Miller, Erin
Kovach, Joshua
Arscott, Patricia
von Alvensleben, Johannes C.
Bradley, David
Valdes, Santiago O.
Ware, Stephanie M.
Meyers, Lindsay
Travers, Curtis D.
Campbell, Robert M.
Etheridge, Susan P.
[J]. HEART RHYTHM, 2020, 17 (01) : 106 - 112
[5] Psychological impact of sports restriction in asymptomatic adolescents with hypertrophic cardiomyopathy, dilated cardiomyopathy, and long QT syndrome
Berg, Alizabeth E.
Meyers, Lindsay L.
Dent, Karin M.
Rothwell, Erin W.
Everitt, Melanie D.
[J]. PROGRESS IN PEDIATRIC CARDIOLOGY, 2018, 49 : 57 - 62
[6] Prevalence, Clinical Presentation, and Management of Channelopathies and Cardiomyopathies, Long QT Syndrome, Brugada Syndrome, Arrhythmogenic Cardiomyopathy, and Hypertrophic Cardiomyopathy
Kristina H. Haugaa
Ida S. Leren
[J]. Current Cardiovascular Risk Reports, 2019, 13
[7] Hypertrophic Cardiomyopathy as an Oligogenic Disease: Transcriptomic Arguments
N. M. Baulina
I. S. Kiselev
O. S. Chumakova
O. O. Favorova
[J]. Molecular Biology, 2020, 54 : 840 - 850
[8] Prevalence, Clinical Presentation, and Management of Channelopathies and Cardiomyopathies, Long QT Syndrome, Brugada Syndrome, Arrhythmogenic Cardiomyopathy, and Hypertrophic Cardiomyopathy
Haugaa, Kristina H.
Leren, Ida S.
[J]. CURRENT CARDIOVASCULAR RISK REPORTS, 2019, 13 (07)
[9] Hypertrophic Cardiomyopathy as an Oligogenic Disease: Transcriptomic Arguments
Baulina, N. M.
Kiselev, I. S.
Chumakova, O. S.
Favorova, O. O.
[J]. MOLECULAR BIOLOGY, 2020, 54 (06) : 840 - 850
[10] Genetic testing for risk stratification in hypertrophic cardiomyopathy and long QT syndrome: fact or fiction?
Ackerman, MJ
[J]. CURRENT OPINION IN CARDIOLOGY, 2005, 20 (03) : 175 - 181

← 1 2 3 4 5 →